长读测序增强了罕见病患者的致病性和新变异发现
Shruti Sinha1, Fatma Rabea2, Sathishkumar Ramaswamy3
1Dubai Health Genomic Medicine Center, Dubai Health, Dubai, UAE. ajch_ssinha@dubaihealth.ae.
Nature communications
|March 15, 2025
概括
长读数测序 (LRS) 通过识别复杂的遗传和表观遗传变异来增强罕见疾病诊断. 这项技术有助于诊断以前未被诊断的患者,包括脊柱肌肉缩患者.
科学领域:
- 基因组学和表观基因组学
- 临床遗传检测 临床遗传检测
- 罕见疾病研究 罕见疾病研究
背景情况:
- 现有的基因检测技术使近一半的罕见病患者没有被诊断出来.
- 长读数测序 (LRS) 提供了作为综合基因分析的统一平台的潜力.
- 需要改进的方法来检测罕见疾病的多种基因组和表观基因组变异.
研究的目的:
- 开发和验证整个基因组LRS数据的简化过策略.
- 增强识别小,大和基于甲基化的致病变体.
- 改善罕见病患者的诊断产量,这些患者之前的遗传检测结果为负.
主要方法:
- 在全基因组长读测序数据上实施了下的过策略.
- 在一组阳性对照组 (N=76) 和一组独立的甲基化资料组 (N=57) 上测试了该方法.
- 将该策略应用于51名患者的队列,他们之前进行过负面的短读遗传测试.
主要成果:
- 该策略成功检测了对照组中的所有致病性单核酸,结构和甲基化变体.
- 在之前负面的短读测试的10%患者中,获得了额外的诊断.
- 确定了诊断脊柱肌肉缩的关键甲基化特征,这是一个可治疗的疾病.
结论:
- 简化的LRS过策略有效地识别出各种致病变异,包括甲基化异常.
- 在临床遗传检测中,LRS显著有用,改善了罕见疾病的诊断率.
- 这种方法有助于发现新的致病变异,并增强诊断能力.
相关概念视频
Next-generation Sequencing
86.7K
The first human genome sequencing project cost $2.7 billion and was declared complete in 2003, after 15 years of international cooperation and collaboration between several research teams and funding agencies. Today, with the advent of next-generation sequencing technologies, the cost and time of sequencing a human genome have dropped over 100 fold.
Next-Generation Sequencing Methods
Although all next-generation methods use different technologies, they all share a set of standard features....
Next-Generation Sequencing Methods
Although all next-generation methods use different technologies, they all share a set of standard features....
86.7K
Sanger Sequencing
752.0K
DNA sequencing is a fundamental technique that is routinely used in the biological sciences. This method can be applied to a range of questions at different scales - from the sequencing of a cloned DNA fragment or the study of a mutation in a gene up to whole-genome sequencing. However, despite the widespread use of sequencing today, it was not until 1977 that Fredrick Sanger and his collaborators developed the chain-termination method to decode DNA sequences. It relies on the separation of a...
752.0K
Genome-wide Association Studies-GWAS
12.3K
Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...
GWAS does not require the identification of the target gene involved in...
12.3K
RNA-seq
9.8K
RNA sequencing, or RNA-Seq, is a high-throughput sequencing technology used to study the transcriptome of a cell. Transcriptomics helps to interpret the functional elements of a genome and identify the molecular constituents of an organism. Additionally, it also helps in understanding the development of an organism and the occurrence of diseases.
Before the discovery of RNA-seq, microarray-based methods and Sanger sequencing were used for transcriptome analysis. However, while...
Before the discovery of RNA-seq, microarray-based methods and Sanger sequencing were used for transcriptome analysis. However, while...
9.8K
Maxam-Gilbert Sequencing
10.8K
In the same year as the discovery of the Sanger sequencing method, another group of scientists, Allan Maxam and Walter Gilbert, demonstrated their chemical-cleavage method for DNA sequencing. The Maxam-Gilbert method relies on using different chemicals that can cleave the DNA sequence at specific sites, the separation of resulting DNA fragments of variable size using electrophoresis, and deciphering the DNA sequence from the resulting gel bands.
Challenges of the Maxam-Gilbert Method
The...
Challenges of the Maxam-Gilbert Method
The...
10.8K
Single Nucleotide Polymorphisms-SNPs
13.8K
A single nucleotide polymorphism or SNP is a single nucleotide variation at a specific genomic position in a large population. It is the most prevalent type of sequence variation found in the human genome. Point mutations that occur in more than 1% of the population qualify as SNPs. These are present once every 1000 nucleotides on an average in the human genome. Replacement of a purine with another purine (A/G) or a pyrimidine with another pyrimidine (C/T) is known as a transition. In contrast,...
13.8K


